参考文献/References:
[1] MINNIG M C C,GOLIGHTLY Y M,NELSON A E.Epidemiology of osteoarthritis:literature update 2022-2023[J].Curr Opin Rheumatol,2024,36(2):108-112.
[2] COURTIES A,KOUKI I,SOLIMAN N,et al.Osteoarthritis year in review 2024:epidemiology and therapy[J].Osteoarthritis Cartilage,2024,32(11):1397-1404.
[3] TSVETKOV P,COY S,PETROVA B,et al.Copper induces cell death by targeting lipoylated TCA cycle proteins[J].Science,2022,375(6586):1254-1261.
[4] HU H,DOU X,HU X,et al.Identification of a novel cuproptosis-related gene signature for rheumatoid arthritis—a prospective study[J].J Gene Med,2023,25(11):e3535.
[5] LING W,LI S,ZHU Y,et al.Inducers of autophagy and cell death:focuson copper metabolism[J].Ecotoxicol Environ Saf,2025,290:117725.
[6] LINDER M C.Copper homeostasis in mammals,with emphasis on secretion and excretion.A Review[J].Int J Mol Sci,2020,21(14):4932.
[7] LIU W Q,LIN W R,YAN L,et al.Copper homeostasis and cuproptosis in cancer immunity and therapy[J].Immunol Rev,2024,321(1):211-227.
[8] PARSANATHAN R.Copper's dual role:unravelling the link between copper homeostasis,cuproptosis,and cardiovascular diseases[J].Hypertens Res,2024,47(5):1440-1442.
[9] MEI J,XIAO N,XI Y,et al.Regulation of apoptosis and interaction with cartilage degeneration in osteoarthritis[J].Front Cell Dev Biol,2025,13:1571448.
[10] CHEN Y,ZENG D,WEI G,et al.Pyroptosis in osteoarthritis:molecular mechanisms and therapeutic implications[J].J Inflamm Res,2024,17:791-803.
[11] CAO S,WEI Y,XIONG A,et al.Paeonol inhibits ACSL4 to protect chondrocytes from ferroptosis and ameliorates osteoarthritis progression[J].J Orthop Translat,2025,50:1-13.
[12] TUNCAY DURU?Z M,?Z N,G?RSOY D E,et al.Clinical aspects and outcomes in osteoarthritis[J].Best Pract Res Clin Rheumatol,2023,37(2):101855.
[13] LI Y,DU Y,ZHOU Y,et al.Iron and copper:critical executioners of ferroptosis,cuproptosis and other forms of cell death[J].Cell Commun Signal,2023,21(1):327.
[14] 黎咏诗,陈鸿,牟平,等.关节液和软骨中微量元素含量与膝关节骨关节炎严重程度的相关性研究[J].中国修复重建外科杂志,2023,37(5):584-588.
[15] ZOU J,BAI B,YAO Y.Progress of co-culture systems in cartilage regeneration[J].Expert Opin Biol Ther,2018,18(11):1151-1158.
[16] GUERRA J P L,PENAS D,TAVARES P,et al.Influence of cupric(Cu2+)ions on the iron oxidation mechanism by DNA-binding protein from starved cells(Dps)from marinobacter nauticus[J].Int J Mol Sci,2023,24(12):10256.
[17] LI G,CHENG T,YU X.The impact of trace elements on osteoarthritis[J].Front Med(Lausanne),2021,8:771297.
[18] BERNHARDT A,BACOVA J,GBURECK U,et al.Influence of Cu2+ on osteoclast formation and activity in vitro[J].Int J Mol Sci,2021,22(5):2451.
[19] KREITMAIER P,SWIFT D,WILKINSON J M,et al.Epi-genomic differences between osteoarthritis grades in primary cartilage[J].Osteoarthritis Cartilage,2024,32(9):1126-1133.
[20] KIM J H,JEON J,SHIN M,et al.Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis[J].Cell,2014,156(4):730-743.
[21] MEYER F,DITTMANN A,KORNAK U,et al.Chondrocytes from osteoarthritic and chondrocalcinosis cartilage represent different phenotypes[J].Front Cell Dev Biol,2021,9:622287.
[22] SAUNIER E,BENELLI C,BORTOLI S.The pyruvate dehydrogenase complex in cancer:an old metabolic gatekeeper regulated by new pathways and pharmacological agents[J].Int J Cancer,2016,138(4):809-817.
[23] PARK S,BAEK I J,RYU J H,et al.PPARα-ACOT12 axis is responsible for maintaining cartilage homeostasis through modulating de novo lipogenesis[J].Nat Commun,2022,13(1):3.
[24] CHE J,YANG X,ZHAO X,et al.Risk factor prediction and immune correlation analysis of cuproptosis-related gene in osteoarthritis[J].J Cell Mol Med,2024,28(15):e18574.
[25] NONG J,LU G,HUANG Y,et al.Identification of cuproptosis-related subtypes,characterization of immune microenvironment infiltration,and development of a prognosis model for osteoarthritis[J].Front Immunol,2023,14:1178794.
[26] CHANG B,HU Z,CHEN L,et al.Development and validation of cuproptosis-related genes in synovitis during osteoarthritis progress[J].Front Immunol,2023,14:1090596.
[27] WANG W,CHEN Z,HUA Y.Bioinformatics prediction and experimental validation identify a novel cuproptosis-related gene signature in human synovial inflammation during osteoarthritis progression[J].Biomolecules,2023,13(1):127.
[28] EMAMI A,NAMDARI H,PARVIZPOUR F,et al.Challenges in osteoarthritis treatment[J].Tissue Cell,2023,80:101992.
[29] BALDARI S,DI ROCCO G,TOIETTA G.Current biomedi-cal use of copper chelation therapy[J].Int J Mol Sci,2020,21(3):1069.
[30] GERBER D A.Inhibition of the denaturation of human gamma globulin by a mixture of D-penicillamine disulfide and copper.A possible mechanism of action of D-penicillamine in rheumatoid arthritis[J].Biochem Pharmacol,1978,27(4):469-472.
[31] QI H,SHI H,YAN M,et al.Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway[J].Cell Death Discov,2023,9(1):259.
[32] ZHOU J,LIU C,SUN Y,et al.Genetically predicted circulating levels of copper and zinc are associated with osteoarthritis but not with rheumatoid arthritis[J].Osteoarthritis Cartilage,2021,29(7):1029-1035.
[33] RELLMANN Y,EIDHOF E,DREIER R.Review:ER stress-induced cell death in osteoarthritic cartilage[J].Cell Signal,2021,78:109880.
[34] SANG Y,ZHANG J,LIU C,et al.Ameliorating osteoarthritis in mice using silver nanoparticles[J/OL].J Vis Exp,2023(196)[2025-02-19].https://pubmed.ncbi.nlm.nih.gov/37335102/.
[35] CAI J,LIU L F,QIN Z,et al.Natural morin-based metal organic framework nanoenzymes modulate articular cavity microenvironment to alleviate osteoarthritis[J].Research(Wash D C),2023,6:0068.
[36] ZHU C,HAN S,ZENG X,et al.Multifunctional thermo-sensitive hydrogel for modulating the microenvironment in Osteoarthritis by polarizing macrophages and scavenging RONS[J].J Nanobiotechnology,2022,20(1):221.
[37] YASSIN N Z,EL-SHENAWY S M,ABDEL-RAHMAN R F,et al.Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis[J].Drug Des Devel Ther,2015,9:1491-1498.
[38] YU B,SUN W,LIN J,et al.Using Cu-based metal-organic framework as a comprehensive and powerful antioxidant nanozyme for efficient osteoarthritis treatment[J].Adv Sci(Weinh),2024,11(13):e2307798.
[39] KUMAR V,SINGH A P,WHEELER N,et al.Safety profile of D-penicillamine:a comprehensive pharmacovigilance analysis by FDA adverse event reporting system[J].Expert Opin Drug Saf,2021,20(11):1443-1450.
相似文献/References:
[1]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[2]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[3]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[4]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):9.
[5]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[6]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[7]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式
和理论体系[J].中医正骨,2015,27(07):1.
[8]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗
骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):6.
[9]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):15.
[10]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):27.